ALTA-2530

N/A

Report date: 2023/01/06 13:25:12

Base Information

Drug NameALTA-2530

Drug Alias NameOSP-101ALTA-2530

ClassificationBiologics > Protein drugs

Mechanisms of ActionInterleukin-1 beta inhibitors

TargetsInterleukin-1 beta

Therapy Area/IndicationsBronchiolitis Obliterans

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAltavant Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAltavant Sciences Inc

Inactive CompaniesN/A

Active IndicationsBronchiolitis Obliterans

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A